Citation Impact
Citing Papers
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease
2009
Periodontitis Associates with a Type 1 IFN Signature in Peripheral Blood Neutrophils
2008
Assessing the human immune system through blood transcriptomics
2010
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Altered Expression of Hepatic Cytochromes P-450 in Mice Deficient in One or More mdr1 Genes
2000
Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice
2005
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
Pharmacokinetics of selective serotonin reuptake inhibitors
2000
Syndemics and the biosocial conception of health
2017 Standout
Drugs as CYP3A Probes, Inducers, and Inhibitors
2007
Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs
2005
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
Microbial tryptophan catabolites in health and disease
2018 Standout
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors
1997
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
2009
Innovative lead discovery strategies for tropical diseases
2006
Juvenile idiopathic arthritis
2007 Standout
Adenosine receptors as therapeutic targets
2006 Standout
A strategy for evaluating pathway analysis methods
2017
The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers
2002
Lymphatic filariasis and onchocerciasis
2010 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Caffeine antinociception: role of formalin concentration and adenosine A1 and A2 receptors
1996
EGL-9 Controls C. elegans Host Defense Specificity through Prolyl Hydroxylation-Dependent and -Independent HIF-1 Pathways
2012
Pharmacokinetic and Pharmacodynamic Interactions Between Zolpidem and Caffeine
2007
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Nonresolving Inflammation
2010 Standout
Selective Serotonin Reuptake Inhibitors: Pharmacologic Profiles and Potential Therapeutic Distinctions
1994
Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
2004
Lung cancer: current therapies and new targeted treatments
2016 Standout
Effect of chronic caffeine intake on choice reaction time, mood, and visual vigilance
2005
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
How the study of children with rheumatic diseases identified interferon‐α and interleukin‐1 as novel therapeutic targets
2008
The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A2A receptors
2000
Update on caffeine consumption, disposition and action
2002
The Serotonin Syndrome
2005 Standout
Pharmacokinetic-Pharmacodynamic Crisis in the Elderly
2006
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
2008
Anxiolytic activity of adenosine receptor activation in mice
1995
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
2015
Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters
2010 Standout
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Multiple dose pharmacokinetics of caffeine administered in chewing gum to normal healthy volunteers
2005
Protective and pathogenic functions of macrophage subsets
2011 Standout
Pseudomonas aeruginosa Disrupts Caenorhabditis elegans Iron Homeostasis, Causing a Hypoxic Response and Death
2013 StandoutNobel
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
2011 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
AGA technical review on irritable bowel syndrome
2002 Standout
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory
1993
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology
2007
River Blindness: A Success Story under Threat?
2006
Helminth infections: the great neglected tropical diseases
2008 Standout
Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease
2009
Immunotherapy in Elderly Transplant Recipients
2009
Psychopharmacologic Treatment of Depression in the Medically Ill
1998
Control of Neglected Tropical Diseases
2007 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective
2004
Beyond EGFR and ALK inhibition: Unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer
2015
Positive Role of CCAAT/Enhancer-Binding Protein Homologous Protein, a Transcription Factor Involved in the Endoplasmic Reticulum Stress Response in the Development of Colitis
2009
Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A1 Receptors
2004
The Role and Regulation of Adenosine in the Central Nervous System
2001 Standout
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
Receptors for Purines and Pyrimidines
1998 Standout
Solution-phase total synthesis of the hydrophilic natural product argifin using 3,4,5-tris(octadecyloxy)benzyl tag
2011 StandoutNobel
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
A Genomic Approach to Human Autoimmune Diseases
2010
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
1998
MET As a Possible Target for Non–Small-Cell Lung Cancer
2013
Observation of the controlled assembly of preclick components in the in situ click chemistry generation of a chitinase inhibitor
2013 StandoutNobel
The health effects of stimulant drinks
2003
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Synthesis and Structure−Activity Relationship in a Class of Indolebutylpiperazines as Dual 5-HT1A Receptor Agonists and Serotonin Reuptake Inhibitors
2004
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
The Immune Response in Tuberculosis
2013 Standout
HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation
2015
STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
2018 Standout
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Creation of Customized Bioactivity within a 14-Membered Macrolide Scaffold: Design, Synthesis, and Biological Evaluation Using a Family-18 Chitinase
2015 StandoutNobel
Using Genetic and Clinical Factors to Predict Tacrolimus Dose in Renal Transplant Recipients
2010
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
2001 Standout
Repositioning of an existing drug for the neglected tropical disease Onchocerciasis
2010
The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
2020 Standout
Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial
2004
Generation of Anti-trypanosomal Agents through Concise Synthesis and Structural Diversification of Sesquiterpene Analogues
2011 StandoutNobel
Works of Monette Cotreau being referenced
Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level
2000
Multiple‐Dose, Safety, Pharmacokinetics, and Pharmacodynamics of a New Selective Estrogen Receptor Modulator, ERA‐923, in Healthy Postmenopausal Women
2002
Molecular Classification of Crohn's Disease and Ulcerative Colitis Patients Using Transcriptional Profiles in Peripheral Blood Mononuclear Cells
2006
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
2005
Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(−/−) mouse liver microsomes
1999
Molecular and Pharmacokinetic Evaluation of Rat Hepatic and Gastrointestinal Cytochrome P450 Induction by Tamoxifen
2001
The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans
2003
Dose‐Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans
1997
In Vitro, Pharmacokinetic, and Pharmacodynamic Interactions of Ketoconazole and Midazolam in the Rat
2002
Fluoxetine impairs clearance of alprazolam but not of clonazepam
1992
Phase Ib study of ficlatuzumab (formerly AV-299), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb) in combination with gefitinib (G) in Asian patients (pts) with NSCLC.
2011
Randomized phase II study of ficlatuzumab (formerly AV-299), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb) in combination with gefitinib (G) in Asian patients (pts) with NSCLC.
2011
Effects of benzodiazepine administration on A1 adenosine receptor binding in-vivo and ex-vivo
1992
Caffeine-induced behavioral stimulation is dose-dependent and associated with A1 adenosine receptor occupancy.
1992
Phase I study of SCH 900105 (SC), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb), as a single agent and in combination with erlotinib (E) in patients (pts) with advanced solid tumors.
2010